| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3873022 | The Journal of Urology | 2010 | 8 Pages |
Abstract
Our results show the synergistic activity of interferon-α and sorafenib. These findings provided the rationale for combination therapy with interferon-α and sorafenib in patients with advanced renal cell carcinoma.
Keywords
PBSIFN-αPDGFβMetastatic RCCRCCCTLmRCCTreginterferon-alphaInterferon-αTILTumor infiltrating lymphocyteRegulatory T cellDendritic cellNatural killer cellRenal cellSorafenibcombination indexplatelet-derived growth factor-βinhibitory concentrationVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)Phosphate buffered salinecytotoxic T lymphocyteAntineoplastic combined chemotherapy protocolsRenal cell carcinomaCarcinomafraction affectedKidney
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ario Takeuchi, Masatoshi Eto, Katsunori Tatsugami, Hisakata Yamada, Toshihiro Oki, Keijiro Kiyoshima, Yasunobu Yoshikai, Seiji Naito,